<?xml version="1.0" encoding="UTF-8"?>
<p id="Par32">In summary, proteomics analysis suggests good biocompatibility of compound 
 <bold>#7</bold> treatment with only limited global effects on protein expression in PBMCs. Profiling these few expression changes by enrichment analysis revealed a set of terms selectively overrepresented in HIV-exposed samples.
</p>
